- Taldefgrobep alfa, a myostatin-targeting biologic investigational agent, in Phase 3 development to increase muscle mass for Spinal Muscular Atrophy patients now granted Fast Track in addition to ...
Read before the Section for Clinical Medicine, Pathology, and Hygiene of the Suffolk District Medical Society, June 9, 1885.
Spinal muscular atrophy is a rare genetic disorder causing progressive muscle weakness, now in focus after Jesy Nelson shared her twins’ diagnosis. Instagram/JesyNelson Spinal muscular atrophy is a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈